Solvias AG
Klybeckstrasse 191
Basel
CH - 4002
Germany
Tel: 41-61-686-61-61
Fax: 41-61-686-65-65
5 articles about Solvias AG
-
Solvias to Perform Release Testing on World's First CRISPR-based Gene-Editing Therapy
1/23/2024
Solvias, a global provider of chemistry, manufacturing, and control analytics, announced that it will perform analytical release testing services on the world's first CRISPR/Cas9 genome-edited cell therapy.
-
Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene Therapy Capabilities
7/12/2022
Solvias, one of the world's leading independent pharmaceutical testing and manufacturing companies, announced that it has acquired Utrecht, Netherlands-based Cergentis.
-
Solvias AG Achieves Solid Growth In 2015, Driven By Innovation, Geographic Expansion And Development Of New Market Segments
3/1/2016
-
Solvias AG Broadens Quality Control Offering To Cover Full Range Of Customer Needs In The Pharma Industry
2/4/2016
-
Patheon and Solvias AG Announce Global Strategic Alliance to Provide Integrated Development Services
11/14/2008